ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

331
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bullishWuxi Biologics
29 Jun 2020 18:42

Wuxi Biologics Placement - This Time It's Different

Wuxi Biologics (Cayman) Inc (2269 HK) is looking to raise around US$660m in a primary placement. This is in contrast to the nine other placement...

Logo
456 Views
Share
29 Jun 2020 16:29

Asia Short Interest Weekly - Big Jump in Japan Shorts

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
296 Views
Share
bullishSamsung C&T
15 Jun 2020 06:26

Korea Synthetic Stubs: C&T at 2-Yr Low, Pure Stub Trade with Biologics

Out of the five synthetic stubs in Korea, two names are in a severe diversion at this point.They are Samsung C&T and CJ Corp.C&T is now at...

Logo
284 Views
Share
13 Jun 2020 10:42

Asia Short Interest Weekly - Shorts Covered as Markets Melted Up

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest across Hong...

Logo
464 Views
Share
05 Jun 2020 04:25

Samsung 1P Discount: Biologics/Elec Equity Swap Dynamics

The Samsung 1P discount had quite a fluctuation lately. It hit the all-time low at 11.77% on May 25. Since then, it soared to 15.48% on May 28 and...

Logo
358 Views
Share
x